Prevention of cardiovascular events after percutaneous coronary intervention.
Herrmann
Howard C
HC
D015906:Angioplasty, Balloon, Coronary; D003327:Coronary Disease / Q000150:complications / Q000628:therapy*; D023903:Coronary Restenosis / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D005492:Folic Acid / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D020138:Hyperhomocysteinemia / Q000150:complications / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012307:Risk Factors; D015607:Stents; D014805:Vitamin B 12 / Q000009:adverse effects / Q000627:therapeutic use; D025101:Vitamin B 6 / Q000009:adverse effects / Q000627:therapeutic use
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D025101:Vitamin B 6; D005492:Folic Acid; D014805:Vitamin B 12